DRIVEN BY OUR PROMISE - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
87168219
Word Mark
DRIVEN BY OUR PROMISE
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2020-07-27
Filing Date
2016-09-12
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2017-05-23
Attorney Name
Law Office Assigned Location Code
L20
Employee Name
RINKER, ANTHONY MICHAE
Statements
Goods and Services
Adjuvants for use in the manufacture of human vaccines and pharmaceutical preparations; excipients in the form of medium components and product stabilizers for use in the manufacture of pharmaceutical preparations
Goods and Services
Pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders; vaccines; blood products in this class, namely, blood plasma, and reagent blood cells for medical diagnostic purposes; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits in the class, namely, in-vitro diagnostic reagent test kits comprised of medical diagnostic reagents for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies; pharmaceutical preparations, namely, clinical medical reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; Antibodies for use in the treatment of infectious diseases, cancer, and autoimmune diseases; drug delivery agents consisting of molecular carrier compounds and other compounds that facilitate delivery of a wide range of pharmaceuticals and drugs; immunomodulators for alteration of immune response in humans
Goods and Services
Surgical and medical apparatus and instruments for use in intravenous administration of pharmaceutical and blood products for the treatment of blood or bleeding disorders and vaccines; analysis apparatus and instruments in this class, namely, apparatus for blood analysis
Goods and Services
Printed matter and publications, namely, printed instructional material and magazines featuring information in the fields of pharmaceutical products, vaccines, blood, blood products, bleeding disorders, blood fractionations, rhesus prophylaxis and human autoimmune disorders; printed instructional and teaching materials in the field of pharmaceutical products, vaccines, blood, blood products, bleeding disorders, blood fractionations, rhesus prophylaxis and human autoimmune disorders; brochures, pamphlets and informational flyers in the field of pharmaceutical products, vaccines, blood, blood products, bleeding disorders, blood fractionations, rhesus prophylaxis and human autoimmune disorders; posters; stationery
Goods and Services
Transport and storage of goods, namely, transport, distribution and storage of blood plasma; transport logistic services, namely, supply chain logistics services in the nature of transportation and delivery of goods by air, rail, ship or truck and consulting services concerning all of the above
Goods and Services
Treatment of biological products, namely, fractionation of blood custom manufacturing of biological products, namely, blood; processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma
Goods and Services
Medical laboratory services, namely, scientific testing and screening services for testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma
Goods and Services
Blood bank services; medical testing and screening services for diagnostic or treatment purposes; medical testing of human blood plasma for diagnostic or treatment purposes; collection of human blood plasma; medical services, namely, providing medical information concerning blood products, providing medical information concerning vaccines, anti-venoms, immunohaematology products and diagnostic reagents; patient support services, namely, providing an Internet-based database of patient medical information where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; health care, namely, providing health care information by telephone, the internet, and through the distribution of printed matter
Classification Information
International Class
016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); playing cards; printers' type; printing blocks. - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); playing cards; printers' type; printing blocks.
US Class Codes
002, 005, 022, 023, 029, 037, 038, 050
Class Status Code
6 - Active
Class Status Date
2016-09-15
Primary Code
016
First Use Anywhere Date
2018-00-00
First Use In Commerce Date
2018-00-00
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-09-15
Primary Code
042
First Use Anywhere Date
2018-00-00
First Use In Commerce Date
2018-00-00
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-09-15
Primary Code
044
First Use Anywhere Date
2018-00-00
First Use In Commerce Date
2018-00-00
Correspondences
Name
Scott D. Woldow
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0068006
Original Filing Date USPTO
2017-06-22
International Registration Number
1387078
International Registration Date
2017-06-22
International Status Code
499
International Renewal Date
2027-06-22
| Madrid History Events | ||
| Date | Code | Description |
| 2021-06-13 | PCBNT | TOTAL CEASING OF EFFECT PROCESSED BY IB |
| 2021-06-13 | PRINX | INTERNATIONAL REGISTRATION CANCELLED BY IB |
| 2021-04-29 | CBMPP | CEASING OF EFFECT PROCESSED |
| 2021-04-29 | CBTSP | TOTAL CEASING OF EFFECT NOTICE SENT TO IB |
| 2017-11-14 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
| 2017-12-14 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2017-12-14 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2017-07-25 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
| 2017-12-13 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2017-10-16 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2017-10-17 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2017-10-17 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2018-02-01 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
| 2017-06-22 | ACERT | AUTOMATICALLY CERTIFIED |
| 2017-06-22 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2017-06-22 | APPST | IR CERTIFIED AND SENT TO IB |
| 2021-04-27 | CBTCP | TOTAL CEASING OF EFFECT TO BE PROCESSED |
Trademark Events
| Event Date | Event Description |
| 2016-09-15 | NEW APPLICATION ENTERED IN TRAM |
| 2016-09-15 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2016-11-16 | ASSIGNED TO EXAMINER |
| 2016-11-21 | NON-FINAL ACTION WRITTEN |
| 2016-11-21 | NON-FINAL ACTION E-MAILED |
| 2016-11-21 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2017-02-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2017-02-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2017-02-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2017-03-16 | FINAL REFUSAL WRITTEN |
| 2017-03-16 | FINAL REFUSAL E-MAILED |
| 2017-03-16 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2017-04-13 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2017-04-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2017-04-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2017-04-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2017-05-03 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2017-05-23 | PUBLISHED FOR OPPOSITION |
| 2017-05-23 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2017-07-18 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2017-12-19 | TEAS EXTENSION RECEIVED |
| 2017-12-19 | EXTENSION 1 FILED |
| 2017-12-19 | EXTENSION 1 GRANTED |
| 2017-12-21 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2018-07-17 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2018-07-17 | TEAS EXTENSION RECEIVED |
| 2018-07-17 | EXTENSION 2 FILED |
| 2018-07-17 | EXTENSION 2 GRANTED |
| 2018-07-19 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2018-12-17 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2018-12-17 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2018-12-17 | TEAS EXTENSION RECEIVED |
| 2018-12-17 | EXTENSION 3 FILED |
| 2018-12-17 | EXTENSION 3 GRANTED |
| 2018-12-19 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-04-26 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2019-04-26 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2019-06-20 | TEAS STATEMENT OF USE RECEIVED |
| 2019-07-11 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2019-06-20 | USE AMENDMENT FILED |
| 2019-07-11 | STATEMENT OF USE PROCESSING COMPLETE |
| 2019-08-16 | SU - NON-FINAL ACTION - WRITTEN |
| 2019-08-16 | NON-FINAL ACTION E-MAILED |
| 2019-08-16 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2019-11-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-11-21 | ASSIGNED TO LIE |
| 2019-11-25 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2019-11-25 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-11-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-12-17 | SU - FINAL REFUSAL - WRITTEN |
| 2019-12-17 | FINAL REFUSAL E-MAILED |
| 2019-12-17 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2020-07-27 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 2020-07-27 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
